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ABSTRACT 
Background: A significant minority of Australians engage in concurrent drug use (using more 
than one drug in a given period).  We examined clusters and correlates of concurrent drug use 
using the latest available nationally representative survey data on Australian young adults.   
Sample.  3836 participants aged 18-29 years (mean age 24 years) from the 2010 National Drug 
Strategy Household Survey (NDSHS).  
Method:  Clusters were distilled using latent class analysis of past year use of alcohol, tobacco, 
cannabis, cocaine, hallucinogens, ecstasy, ketamine, GHB, inhalants, steroids, barbiturates, 
meth/amphetamines, heroin, methadone/buprenorphine, other opiates, painkillers and 
tranquillizers/sleeping pills.  
Results: Concurrent drug use in this sample was best described using a 4-class solution. The 
majority (87.5%) of young adults predominantly used alcohol only (50.9%) or alcohol and 
tobacco (36.6%). 10.2% reported using alcohol, tobacco, marijuana, and ecstasy, and 2.3% 
reported using an extensive range of drugs.   
Conclusion:  Most drug use clusters were robust in their profile and stable in their prevalence, 
indicating little meaningful change at the population level from 2007.  The targeting of alcohol 
and tobacco use remains a priority, but openness to experiencing diverse drug-related effects 
remains a significant concern for 12.5% of young people in this age group.   
 
Key words: [young adults, concurrent drug use, polydrug use, latent class analysis, cluster, risk 
and protective factors] 
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INTRODUCTION 
Concurrent use (here defined as the use of more than one drug in a specified period, typically 1-
12 months) is highly prevalent in young adulthood (Carter et al., 2013; Chen, Yi, & Moss, 2013; 
Chiauzzi, DasMahapatra, & Black, 2013; Chung, Kim, Hipwell, & Stepp, 2013; Font-Mayolas et 
al., 2013; Reyes, Perez, Colon, Dowell, & Cumsille, 2013; White et al., 2013).  When drugs are 
combined, there are risks of cumulative and synergistic effects on brain function (Connor, Gullo, 
White, & Kelly, 2014; Licata & Renshaw, 2010) and mental health problems (Quek et al., 2013; 
Smith, Farrell, Bunting, Houston, & Shevlin, 2011; White et al., 2013).   In an analysis of the 
2007 national survey data (AIHW, 2008), we examined the extent to which a nationally 
representative sample young adults aged 18-29  years used different combinations of alcohol, 
tobacco, and other drugs.  We established five clusters of substance use: the majority of young 
adults predominantly used alcohol only (52.3%), or alcohol and tobacco (34.2%). The other 
classes were cannabis, ecstasy, and licit drug use (9.4%), cannabis, amphetamine derivative, and 
licit drug use (2.8%), and sedative and alcohol use (1.3%).   
In this paper we replicated this analysis for the 2010 national survey data (AIHW, 2011) to 
assess the robustness of drug use clusters, and whether there had been changes from 2007 to 
2010 in patterns and correlates of concurrent drug use.  As in our analysis of the 2007 data and 
related research (Carter et al., 2013; Chung et al., 2013; Smith et al., 2011), we examined the use 
of one or more substances in the previous year.  The use of this time frame means that proximity 
of  the use of different substances is closer than studies that use lifetime prevalence data on 
polydrug use (Agrawal, Lynskey, Madden, Bucholz, & Heath, 2007; Connor et al., 2014; 
Lynskey et al., 2006; White et al., 2013), and cell sizes for clusters are sufficiently large to 
permit analysis of predictors of cluster membership.   
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MATERIAL AND METHODS 
Sample 
The sample consisted of 3836 participants in the 2010 National Drug Strategy Household Survey 
(AIHW, 2011) who were aged 18- 29 years (42.3% male; mean age = 23.97; SD = 3.49). Of 
these, 335 (8.7%) were excluded due to non-response on any of the drug-related items and 26 
were excluded because they reported completing the questionnaire in the presence of another 
person where the honesty of their answers may have been affected.  These exclusion criteria 
were the same as those applied to 2007 NDSHS data.  
Measures 
The measures were identical to those applied in our prior study of 2007 data (Quek et al., 2013).  
Concurrent drug use was based on >1 drug used in the past year [alcohol/tobacco/marijuana/ 
ecstasy/tranquillisers or sleeping pills/cocaine/hallucinogens/meth or amphetamine/pain-killers 
or analgesics, for non-medical purposes in the last 12 months].  Responses for each drug were 
coded as 0 “No” and 1 “Yes”.  For the purposes of examining similarities across and within 
clusters, a range of potential covariates were measured.   Covariates including in the analysis 
were: sex, couple relationship status (0 “Not partnered” and 1 “partnered”), high school 
completion (0 “completed”, 1 “not completed”), income levels (0” $41600 or above”, 1 
“$13000-41599”, 2 “$12999 or below”, 3 “prefer not to say/ don’t know”), language spoken at 
home (0 “English”, 1 “non-English”),  regionality (1 “major cities”, 2 “inner regional”, 3 “outer 
regional/ remote/ very remote”) (ABS, 2009), and depressive symptoms measured by the Kessler 
10 scale (Kessler et al., 2003). 
Survey Procedure 
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Participants were from all Australian States and Territories, and were randomly selected using a 
stratified design based on statistical local area (AIHW, 2011). Access to the survey data was 
approved by the Australian Social Science Data Archive and by the University of Queensland 
Human Research Ethics Committee. 
Analysis 
As per our analysis of 2007 data, Latent Class Analysis (LCA) was used to analyse drug use.  
The number of classes was determined using: Bayesian Information Criteria (BIC) (Schwarz, 
1978), Sample size adjusted Bayesian Information Criterion (SSABIC) (Sclove, 1987), and the 
Akaike Information Criterion (AIC) (Akaike, 1974), with lower values for each indicating 
optimal balance of model parsimony and model fit. The Lo-Mendell-Rubin adjusted likelihood 
ratio test (Lo, Mendell, & Rubin, 2001) was used to compare the fit of a model with k classes to 
a model with k-1 classes. Entropy and average posterior probabilities were used to evaluate the 
classification quality.  The number of significant bivariate residuals was used to access the 
validity of the local independence assumption of LCA. Once the optimal number of classes was 
determined, covariates were added to the model to examine their associations with latent classes. 
All analyses were performed with Mplus 6.01  (Muthén & Muthén, 2011). 
RESULTS 
A six-class solution attained the lowest value of AIC, a four-class solution attained the lowest 
value of BIC and a five-class solution attained the lowest value of SSABIC. Results from the 
LMR-LRT suggested that a four-class solution fitted the data significantly better than the three-
class solution and not significantly worse than a five-class solution. Simulation suggested that 
the performance SSABIC and LMR-LRT were better than other criteria in model selection 
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(Nylund, Asparouhov, & Muthén, 2007; Yang, 2006). However, since these two statistics 
pointed to two different solutions, both were examined on the basis of interpretability and 
usefulness of the classification (Muthén & Muthén, 2000). In the four-class solution, an extended 
range concurrent drug using class was identified. This group was further broken down into two 
sub-classes in the five class solution each with a very small prevalence estimates, namely, a class 
with very high probabilities of using all the drugs, and a class with a very high probability of 
using all alcohol, tobacco, marijuana and pain killers, and a moderate probability of using 
tranquilisers. A comparison of the participants in these two classes indicated that they had very 
similar demographic profiles. The four-class solution was chosen as the optimal solution as it 
yielded classifications that was clearly distinct and interpretable, and had adequate class sizes 
with high average posterior probabilities.  Average posterior probabilities were over 0.80 for all 
classes. 
Each of the four classes was described below using the probabilities of drugs use in the past 12 
months (see Figure 1). Nomenclature for each class was based on the type and range of 
substances with posterior probabilities greater than 0.65.  Class 1 (“Alcohol only”): Participants 
in this cluster (50.9%) were predominantly alcohol users (0.78 probability of alcohol use), with a 
small probability (0.07) of tobacco use and nearly zero probabilities of other drug use. Class 2 
(“Alcohol and tobacco”): Participants in this class (36.6%) reported nearly universal alcohol use 
(0.99), high probability of tobacco use (0.69), moderate probability of marijuana use (0.32) and 
negligible probabilities of other drug use (below 0.05).  Class 3 (“Marijuana, ecstasy and other 
licit drug use”): Participants in this cluster (10.2%) reported nearly universal alcohol use (0.99), 
high probability of tobacco, marijuana and ecstasy use (above 0.67), moderate probability of 
cocaine, hallucinogens and amphetamine use (0.32 – 0.37) and low probabilities of other drug 
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use.  Class 4 (“Extended concurrent drug use”): Participants in this cluster (2.3%) reported 
universal alcohol use (1.00), high probability of tobacco, marijuana, ecstasy, 
tranquillisers/sleeping pills, cocaine, amphetamine and pain killers/ analgesics use (above 0.63), 
and moderate probabilities of hallucinogens (0.47).  Relative to the Alcohol only class, the 
following findings were significant covariates that predicted membership in the multiple 
concurrent drug using classes (see Table 1):  being male (Class 2, p < .05, Class 3, p < .001, 
respectively), not completing high school (all classes, p < .05), not having a partner (all classes, p 
< .05), low income level (Class 3, p < .001), depressive symptoms (p < .001), and coming from 
an English speaking home (p < .001).  Regionality was unrelated to cluster membership.   
[INSERT TABLE 1 ABOUT HERE] 
[INSERT FIGURE 1 ABOUT HERE] 
DISCUSSION 
The overall objective of this study was to examine drug use clusters, their prevalence and 
correlates using the latest available (2010) nationally representative survey data.   A four cluster 
solution was the most robust and interpretable and the key risk markers of cluster membership 
were being male and not competing high school.  Coming from a non-English speaking home 
and having a partner were protective markers.  There were close parallels between the 2007 and 
the 2010 clusters – both the present study and our earlier study identified an alcohol only cluster, 
an alcohol and tobacco cluster, and a marijuana, ecstacy and other licit drug use cluster.  Our 
earlier study found evidence of a distinct cluster alcohol and sedatives/tranquilisers.  In the 
present study this cluster was not replicated.  Instead, posterior probabilities for  
sedatives/tranquiliser use were high in the extended concurrent drug use cluster.  In our earlier 
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study, we noted that the sedatives and alcohol cluster was quite small (1.3%) and it is possible 
that this cluster was statistically unstable.  
We were able to make cautious observations about the relative prevalence of drug clusters from 
2007 to 2010, given the similarity of the clusters across surveys.  There was some variation in 
the proportions of the sample that fell into each cluster, but variations across the two surveys 
were within measurement error.  For alcohol only, the proportion was 50.9 ± 1.7%  in 2010, and 
52.3 ± 1.8% in 2007.  The cluster alcohol and tobacco had a proportion of 36.6  ± 1.6%  in 2010 
and 34.2 ± 1.8% in 2007.  For cannabis, ecstasy and licit drug use, the proportion was 10.22 ± 
1.0% in 2010 and 9.63 ± 1.1% in 2007.  Finally, the proportion of those in the extended 
concurrent drug use was 2.3 ± 0.5% in 2010 and 2.8 ± 0.5% in 2007.  In all, the comparison of 
the 2007 and 2010 results showed no evidence of change.  Cross-year survey replications like the 
National Drug Strategy Household Survey are an ideal benchmark to evaluate the impact of 
population level policies and programs targeting concurrent drug use.  The clustering of alcohol 
and tobacco for a large proportion of young adults was robust, and is perhaps of greatest concern, 
given that tobacco and alcohol are the leading contributors to drug-related public health costs 
(Collins & Lapsley, 2008; Kelly, 2012).  More research is needed on the extent to which alcohol 
consumption is a contextual antecedent to smoking in young adults (Kelly & Jackson-Carroll, 
2007; Kelly et al., 2011).   Longitudinal research on the association of concurrent drug use and 
senior school noncompletion is needed.  Screening and brief advice/counselling in settings such 
as employment services, trade schools and technical colleges may assist in reducing the apparent 
broadening of substance use profiles that occurs over the transition to young adulthood (Chen et 
al., 2013).   
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While replication of earlier found clusters points to the robustness of findings, we have 
previously noted the limitations of these surveys.  Individuals with severe problems may be 
under-represented in this survey.  The design is cross-sectional and so conclusions cannot be 
made about causality, progression, and sequencing.  The study relies on self-report, although the 
confidential and anonymous nature of participation is likely to have reduced response bias.  
Findings may vary with the frequency/severity of substance use, which was not assessed.  
Reports of the use of different substances within the past year (the present measure) may be more 
likely to capture proximal use compared to lifetime prevalence rates, but the use of individual 
substances may be temporally or functionally unrelated.    
.    
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Table 1.  
Odd ratios and 95% confidence intervals with Alcohol only class as the reference group. 
 
Alcohol and tobacco 
Marijuana, ecstasy and 
other illicit drug use 
Extended concurrent drug 
use 
 OR 95% CI OR 95% CI OR 95% CI 
Age 0.99 (0.99, 1.03) 0.95 (0.95, 1.02) 0.93 (0.93, 1.08) 
Female (Ref: Male) 0.75** (0.75, 0.95) 0.45*** (0.45, 0.68) 0.45 (0.45, 1.04) 
Not Completed high school 1.55*** (1.55, 2.03) 1.08* (1.08, 1.82 1.40** (1.4, 3.45) 
Couple status -  Partnered (Ref. not 
partnered) 
0.74** (0.74, 0.96) 0.45*** (0.45, 0.76) 0.30* (0.30, 0.86) 
Income level (Ref: $41,600 or above)     
  $13000 - $41599 0.99 (0.99, 1.32) 0.67*** (0.67, 1.13) 0.45 (0.45, 1.41) 
  $12999 or below 0.76 (0.76, 1.10) 0.35*** (0.35, 0.74) 0.48 (0.48, 1.98) 
  Prefer not to say/ Don't know 0.66* (0.66, 0.96) 0.12*** (0.12, 0.30) 0.16* (0.16, 0.88) 
Remoteness (Ref: Major cities)      
  Inner regional 0.83 (0.83, 1.11) 0.60 (0.6, 1.08) 0.40 (0.40, 1.20) 
  Outer regional/ remote/ very remote 0.88 (0.88, 1.22) 0.53 (0.53, 1.04) 0.40 (0.40, 1.38) 
Non-English speaking background 0.39*** (0.39, 0.58) 0.11*** (0.11, 0.34) 0.10* (0.10, 0.85) 
Depressive symptoms 1.03*** (1.03, 1.05) 1.04*** (1.04, 1.08) 1.08*** (1.08, 1.13) 
Notes.  * p < .05; ** p < .01; *** p < .001.
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Figure 1. Probabilities of using each drug type for the four classes identified in the latent class analysis. 
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HIGHLIGHTS 
 We focused on drug use profiles in a large nationally representative survey (2010)  
 There were four clusters of concurrent drug use amongst young adults (18-29 years) 
 Of those who used any drug, about half concurrently used 2 or more drugs (past year) 
 There was little meaningful change in drug clusters from 2007 
